Form 4: Adaptive Biotechnologies' Chief People Officer, Francis Lo, Reports Stock Transactions
SEC Form 4 Filing
Francis Lo, Chief People Officer of Adaptive Biotechnologies, reports the acquisition and disposal of company stock and stock options related to vesting RSUs and tax obligations.
Summary
- On March 4, 2025, Francis Lo, Chief People Officer of Adaptive Biotechnologies, acquired 99,976 shares of common stock.
- Also on March 4, 2025, Lo acquired options to purchase 150,024 shares of common stock at an exercise price of $8.12, vesting in installments starting March 4, 2026.
- On March 5, 2025, Lo disposed of 7,085 shares at $6.98 and 13,790 shares at $6.99 to cover tax withholding obligations related to vesting RSUs.
- Following these transactions, Lo directly owns 332,846 shares of common stock and indirectly owns 2,500 shares through You Jin Lee (spouse).
- Lo also directly owns options for 150,024 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine transactions related to compensation and tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider trading activity related to compensation.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of common stock acquisition and stock option grant. |
| 03/05/2025 | Date of common stock disposal to cover tax obligations. |
| 03/04/2026 | First vesting date for 1/4 of the stock options. |
| 03/04/2035 | Expiration date of the stock options. |
| 03/06/2025 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.